MDD Revision Clarifies Existing Policies, Tightens Industry Loopholes
This article was originally published in The Gray Sheet
Executive Summary
A draft revision of the European Medical Devices Directive would give manufacturers of implantable and Class III devices less leeway to avoid clinical evaluation requirements